With new biotechnology being released daily, what we once knew in the medical field is being replaced by new discoveries. Harvard medical school reported that the half-life of medical knowledge was 18 to 24 months and is predicted to be decreasing rapidly.
In this episode, Greg DuPont is joined again by John McConnel to talk about what the future holds for the rapid advancements in biotech. With the possibility of an extended life span, what does it mean for the stock market and your retirement planning?
Greg and John discuss:
- Where biotech is headed
- What the advancement in medicine has done for patients already
- Changing your priorities when planning for the future
- The effect baby boomers can have on the stock market
- And more!
Connect with Gregory DuPont:
Connect with John McConnell:
About our guest:
John is passionate about sharing the truth around retirement planning. He started his career at Morgan Stanley and progressed into a long-term care and disability brokerage firm. He was later recruited by MetLife as one of six product specialists throughout the country. John was then sought out by one of the country’s largest distributors of retirement solutions before returning to his true calling of helping retirees navigate this unusual time that we now live in.